Confirmed Financial, Advisory and Investors Include:11.2 Capital
4BIO Capital Alpha Bronze ALSA Holdings Ltd. Ample Plus Fund Astellas Venture Management LLC BioSense Global LLC Bohe Angel Fund Bpifrance Investissement Brookline Capital Markets Cleveland Clinic Connetic Ventures Dana-Farber Cancer Institute ESC Advisors F1BioVentures, LLC H.C. Wainwright & Co. JAFCO Co., Ltd. L.E.K. Consulting Ladenburg Thalmann Lilly Asian Ventures Locust Walk Loncar Investment, LLC Mediqventures Milestone Capital MPM Capital New Enterprise Associates New Science Global Healthcare Fund Oppenheimer & Co., Inc. OrbiMed Advisors LLC Prevail Partners LLC RA Capital Management RBC Capital Markets Sangel Capital Suenos Advisors Est. UNUM Capital venBio Select Vida Ventures WBB Securities WG Partners LLP |
4TH ANNUAL IMMUNO-ONCOLOGY BD&L AND INVESTMENT FORUM
WALDORF ASTORIA CHICAGO HOTEL, USA
INVESTORS & ANALYSTS
Sachs Associates Switzerland AG
|
Sachs Associates Ltd.
|
T: +44 203 463 4890
E: [email protected]
© COPYRIGHT 2023. ALL RIGHTS RESERVED.